Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
56.36 EUR | +0.71% | +1.95% | +6.99% |
09-13 | Berenberg rates Covestro at 'Hold' - Target 58 euros | DP |
09-13 | COVESTRO : Berenberg gives a Neutral rating | ZD |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 12.41B | 10.71B | 15.9B | 17.97B | 14.38B | |||||
Total Revenues | 12.41B | 10.71B | 15.9B | 17.97B | 14.38B | |||||
Cost of Goods Sold, Total | 9.66B | 8.21B | 11.48B | 15.05B | 12.05B | |||||
Gross Profit | 2.75B | 2.5B | 4.43B | 2.92B | 2.33B | |||||
Selling General & Admin Expenses, Total | 1.78B | 1.53B | 1.86B | 1.93B | 1.86B | |||||
R&D Expenses | 266M | 262M | 341M | 361M | 374M | |||||
Other Operating Expenses | -1M | 15M | 34M | -68M | -43M | |||||
Other Operating Expenses, Total | 2.05B | 1.81B | 2.24B | 2.22B | 2.2B | |||||
Operating Income | 706M | 693M | 2.19B | 697M | 134M | |||||
Interest Expense, Total | -85M | -73M | -79M | -148M | -160M | |||||
Interest And Investment Income | 44M | 31M | 43M | 69M | 77M | |||||
Net Interest Expenses | -41M | -42M | -36M | -79M | -83M | |||||
Income (Loss) On Equity Invest. | -20M | -12M | -13M | -15M | -19M | |||||
Currency Exchange Gains (Loss) | 5M | 3M | 1M | -9M | 7M | |||||
Other Non Operating Income (Expenses) | -4M | -16M | -11M | -16M | -2M | |||||
EBT, Excl. Unusual Items | 646M | 626M | 2.13B | 578M | 37M | |||||
Restructuring Charges | - | - | - | - | - | |||||
Merger & Related Restructuring Charges | - | -32M | -3M | - | - | |||||
Impairment of Goodwill | - | - | - | -33M | -7M | |||||
Gain (Loss) On Sale Of Investments | 19M | - | - | - | - | |||||
Gain (Loss) On Sale Of Assets | 34M | -1M | - | - | 35M | |||||
Asset Writedown | -1M | -9M | 2M | -415M | 8M | |||||
Insurance Settlements | 63M | 21M | 20M | - | 75M | |||||
Legal Settlements | - | - | - | - | - | |||||
Other Unusual Items | - | 0 | 33M | - | -75M | |||||
EBT, Incl. Unusual Items | 761M | 605M | 2.18B | 130M | 73M | |||||
Income Tax Expense | 204M | 151M | 566M | 411M | 275M | |||||
Earnings From Continuing Operations | 557M | 454M | 1.62B | -281M | -202M | |||||
Net Income to Company | 557M | 454M | 1.62B | -281M | -202M | |||||
Minority Interest | -5M | 5M | -3M | 9M | 4M | |||||
Net Income - (IS) | 552M | 459M | 1.62B | -272M | -198M | |||||
Net Income to Common Incl Extra Items | 552M | 459M | 1.62B | -272M | -198M | |||||
Net Income to Common Excl. Extra Items | 552M | 459M | 1.62B | -272M | -198M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 3.02 | 2.48 | 8.37 | -1.42 | -1.05 | |||||
Basic EPS - Continuing Operations | 3.02 | 2.48 | 8.37 | -1.42 | -1.05 | |||||
Basic Weighted Average Shares Outstanding | 183M | 185M | 193M | 191M | 189M | |||||
Net EPS - Diluted | 3.02 | 2.48 | 8.37 | -1.42 | -1.05 | |||||
Diluted EPS - Continuing Operations | 3.02 | 2.48 | 8.37 | -1.42 | -1.05 | |||||
Diluted Weighted Average Shares Outstanding | 183M | 185M | 193M | 191M | 189M | |||||
Normalized Basic EPS | 2.18 | 2.14 | 6.89 | 1.94 | 0.14 | |||||
Normalized Diluted EPS | 2.18 | 2.14 | 6.89 | 1.94 | 0.14 | |||||
Dividend Per Share | 1.2 | 1.3 | 3.4 | - | - | |||||
Payout Ratio | 79.53 | 47.71 | 15.53 | -240.44 | -2.02 | |||||
American Depositary Receipts Ratio (ADR) | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |||||
Supplemental Items | ||||||||||
EBITDA | 1.3B | 1.28B | 3B | 1.58B | 806M | |||||
EBITA | 720M | 707M | 2.25B | 764M | 193M | |||||
EBIT | 706M | 693M | 2.19B | 697M | 134M | |||||
EBITDAR | 1.32B | 1.3B | 3.02B | 1.6B | 824M | |||||
Effective Tax Rate - (Ratio) | 26.81 | 24.96 | 25.9 | 316.15 | 376.71 | |||||
Total Current Taxes | 126M | 199M | 628M | 383M | 299M | |||||
Total Deferred Taxes | 78M | -48M | -62M | 28M | -24M | |||||
Normalized Net Income | 399M | 396M | 1.33B | 370M | 27.12M | |||||
Interest Capitalized | 6M | 8M | 3M | 3M | 12M | |||||
Interest on Long-Term Debt | 33M | 28M | 26M | 25M | 74M | |||||
Non-Cash Pension Expense | 32M | 32M | 19M | 22M | 15M | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 1.38B | 1.2B | 1.43B | 1.56B | 1.49B | |||||
General and Administrative Expenses | 372M | 310M | 415M | 353M | 360M | |||||
Research And Development Expense From Footnotes | 266M | 262M | 341M | 361M | 374M | |||||
Net Rental Expense, Total | 20M | 16M | 18M | 21M | 18M | |||||
Imputed Operating Lease Interest Expense | 9.85M | 4.48M | 4.36M | 8.14M | 7.03M | |||||
Imputed Operating Lease Depreciation | 10.15M | 11.52M | 13.64M | 12.86M | 10.97M | |||||
Stock-Based Comp., Other (Total) | 16M | 23M | 17M | 9M | 57M | |||||
Total Stock-Based Compensation | 16M | 23M | 17M | 9M | 57M |